L-carnitine ameliorates the muscle wasting of cancer cachexia through the AKT/FOXO3a/MaFbx axis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
L-carnitine ameliorates the muscle wasting of cancer cachexia through the AKT/FOXO3a/MaFbx axis
Authors
Keywords
-
Journal
Nutrition & Metabolism
Volume 18, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-11-01
DOI
10.1186/s12986-021-00623-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Differential structural features in soleus and gastrocnemius of carnitine-treated cancer cachectic rats
- (2019) Sílvia Busquets et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Giving combined medium‐chain fatty acids and glucose protects against cancer‐associated skeletal muscle atrophy
- (2019) Takuya Mori et al. CANCER SCIENCE
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer-associated cachexia
- (2018) Vickie E. Baracos et al. Nature Reviews Disease Primers
- Cancer Cachexia: Cause, Diagnosis, and Treatment
- (2017) Todd W. Mattox NUTRITION IN CLINICAL PRACTICE
- Unknown
- (2017) Xinling Zhang et al. Oncotarget
- A systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer: a European Palliative Care Research Centre cachexia project
- (2016) Mochamat et al. Journal of Cachexia Sarcopenia and Muscle
- L-Carnitine Ameliorates Cancer Cachexia in Mice Partly via the Carnitine Palmitoyltransferase-Associated PPAR-γ Signaling Pathway
- (2015) Fang Jiang et al. Oncology Research and Treatment
- AMPK Reverses the Mesenchymal Phenotype of Cancer Cells by Targeting the Akt–MDM2–Foxo3a Signaling Axis
- (2014) Chih-Chien Chou et al. CANCER RESEARCH
- Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways
- (2014) J. Rodriguez et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Resveratrol prevents TNF-α-induced muscle atrophy via regulation of Akt/mTOR/FoxO1 signaling in C2C12 myotubes
- (2014) Dong-Tao Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Ligustilide prevents the apoptosis effects of tumour necrosis factor-alpha during C2C12 cell differentiation
- (2014) Ying Shi et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Mechanisms regulating skeletal muscle growth and atrophy
- (2013) Stefano Schiaffino et al. FEBS Journal
- The Role of Inflammatory Pathways in Cancer-Associated Cachexia and Radiation Resistance
- (2013) A. Laine et al. MOLECULAR CANCER RESEARCH
- Parthenolide from Parthenium integrifolium reduces tumor burden and alleviate cachexia symptoms in the murine CT-26 model of colorectal carcinoma
- (2013) Yang Quanjun et al. PHYTOMEDICINE
- Potential Inhibitory Effects of l-Carnitine Supplementation on Tissue Advanced Glycation End Products in Patients with Hemodialysis
- (2013) Kei Fukami et al. REJUVENATION RESEARCH
- Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
- (2012) Kenneth C.H. Fearon et al. Cell Metabolism
- l-Carnitine: An adequate supplement for a multi-targeted anti-wasting therapy in cancer
- (2012) Sílvia Busquets et al. CLINICAL NUTRITION
- Resveratrol prevents dexamethasone-induced expression of the muscle atrophy-related ubiquitin ligases atrogin-1 and MuRF1 in cultured myotubes through a SIRT1-dependent mechanism
- (2011) Nima Alamdari et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- L-carnitine ameliorates cancer cachexia in mice by regulating the expression and activity of carnitine palmityl transferase
- (2011) Su Liu et al. CANCER BIOLOGY & THERAPY
- Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia?
- (2011) Celena Scheede-Bergdahl et al. CLINICAL NUTRITION
- Definition and classification of cancer cachexia: an international consensus
- (2011) Kenneth Fearon et al. LANCET ONCOLOGY
- Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
- (2010) Xiaolan Zhou et al. CELL
- Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia
- (2010) G. Mantovani et al. ONCOLOGIST
- Smad2 and 3 transcription factors control muscle mass in adulthood
- (2009) Roberta Sartori et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Mechanisms of Cancer Cachexia
- (2009) Michael J. Tisdale PHYSIOLOGICAL REVIEWS
- The role of cytokines in cancer cachexia
- (2009) Josep M Argilés et al. Current Opinion in Supportive and Palliative Care
- Cancer cachexia: Developing multimodal therapy for a multidimensional problem
- (2008) K.C.H. Fearon EUROPEAN JOURNAL OF CANCER
- Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results
- (2008) Giovanni Mantovani et al. NUTRITION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation